Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir.

George EC, Bucciardini R, Richert L, Dedes N, Fragola V, Nieuwkerk P, Spire B, Volny-Anne A, West B, Molina JM, Horban A, Fox J, Pozniak A, Vella S, Termote M, Raffi F; NEAT 001/ANRS 143 Study Group.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):519-526. doi: 10.1097/QAI.0000000000001844.

2.

Usage of purchased self-tests for HIV infections among migrants living in the UK, France and the Netherlands: a cross-sectional study.

Bil JP, Prins M, Fakoya I, Volny-Anne A, Burns F, Zuure FR.

Sex Transm Infect. 2019 Dec;95(8):629-632. doi: 10.1136/sextrans-2018-053583. Epub 2018 Aug 31.

PMID:
30171170
3.

HIV testing history and access to treatment among migrants living with HIV in Europe.

Fakoya I, Álvarez-Del Arco D, Monge S, Copas AJ, Gennotte AF, Volny-Anne A, Wengenroth C, Touloumi G, Prins M, Barros H, Darling KE, Prestileo T, Del Amo J, Burns FM; aMASE Study Team.

J Int AIDS Soc. 2018 Jul;21 Suppl 4:e25123. doi: 10.1002/jia2.25123.

4.

Factors Associated With Access to HIV Testing and Primary Care Among Migrants Living in Europe: Cross-Sectional Survey.

Fakoya I, Álvarez-Del Arco D, Copas AJ, Teixeira B, Block K, Gennotte AF, Volny-Anne A, Bil JP, Touloumi G, Del Amo J, Burns FM.

JMIR Public Health Surveill. 2017 Nov 6;3(4):e84. doi: 10.2196/publichealth.7741.

5.

High levels of postmigration HIV acquisition within nine European countries.

Alvarez-Del Arco D, Fakoya I, Thomadakis C, Pantazis N, Touloumi G, Gennotte AF, Zuure F, Barros H, Staehelin C, Göpel S, Boesecke C, Prestileo T, Volny-Anne A, Burns F, Del Amo J; Advancing Migrant Access to Health Services in Europe (aMASE) study team.

AIDS. 2017 Sep 10;31(14):1979-1988. doi: 10.1097/QAD.0000000000001571.

PMID:
28857779
6.

Evaluating patient preference and satisfaction for human immunodeficiency virus therapy in France.

Brégigeon-Ronot S, Cheret A, Cabié A, Prazuck T, Volny-Anne A, Ali S, Bottomley C, Finkielsztejn L, Philippe C, Parienti JJ.

Patient Prefer Adherence. 2017 Jul 10;11:1159-1169. doi: 10.2147/PPA.S130276. eCollection 2017.

7.

Advancing Migrant Access to Health Services in Europe (AMASE): Protocol for a Cross-sectional Study.

Fakoya I, Álvarez-Del Arco D, Monge S, Copas AJ, Gennotte AF, Volny-Anne A, Göpel S, Touloumi G, Prins M, Barros H, Staehelin C, Del Amo J, Burns FM.

JMIR Res Protoc. 2016 May 16;5(2):e74. doi: 10.2196/resprot.5085.

8.

Dosing antiretroviral medication when crossing time zones: a review.

Lewis JM, Volny-Anne A, Waitt C, Boffito M, Khoo S.

AIDS. 2016 Jan;30(2):267-71. doi: 10.1097/QAD.0000000000000920. Review.

9.

Enhancing patient self-management.

Volny-Anne A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19496. doi: 10.7448/IAS.17.4.19496. eCollection 2014.

Supplemental Content

Loading ...
Support Center